See red below
It's about time someone gets nailed for this
In particular, there are questions regarding the accuracy and completeness of REVO's public assertions relating to, among other things: (1) REVO's license of certain patents to Eyetalk365, LLC ("Eyetalk"), including a $900,000 "in consideration" fee paid by Eyetalk to REVO and related net income received by REVO; (2) a line of credit of up to $10 million obtained by REVO's wholly-owned subsidiary, Greenwood Finance Group, LLC ("Greenwood"); (3) Greenwood's ownership of $7 million of promissory notes, and interest payments made to Greenwood in connection with such promissory notes with a projected possible cash value exceeding $1 million; and (4) REVO's possible plans to issue dividends and buy back shares of its common stock.
